Faculty profile

Samy Suissa

ResearcherMedicineMcGill University

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a McGill University directory, so their courses may be missing. Find their university profile.

Samy Suissa

Researcher

Medicine

Health Sciences

McGill University

Montreal, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
77 publications in the last five years, latest in 2026.
Senior (last) author on 20 recent papers, a sign of leading a research group.
Principal investigator on 13 research grants (12 CIHR, 1 NSERC), most recently in 2025.
Supervisor on 2 trainee awards (2 CIHR), most recently in 2012.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

325

Publications

849

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Pharmacoepidemiology Dsen Observational Studies Drug Safety And Effectiveness Asthma Bias Cardiovascular Events Case-Crossover

Latest papers

Transient Oral Corticosteroid Use and Acute Upper Gastrointestinal Bleeding in Mild-to-Moderate Asthma: A Case-Crossover Study.
Drug safety · 2026 · senior author
Comparative Effectiveness and Safety of Fluticasone-Umeclidinium-Vilanterol and Beclomethasone-Glycopyrronium-Formoterol Single-Inhaler Triple Therapies for COPD: Real-World Observational Study [Response to Letter].
International journal of chronic obstructive pulmonary disease · 2026 · senior author
Comparative Effectiveness and Safety of Fluticasone-Umeclidinium-Vilanterol and Beclomethasone-Glycopyrronium-Formoterol Single-Inhaler Triple Therapies for COPD: Real-World Observational Study.
International journal of chronic obstructive pulmonary disease · 2026 · senior author

All 325 publications

Latest funding

Sex differences in the risk of severe exacerbations associated with sedative drugs alone or in combination in patients with chronic obstructive pulmonary disease
CIHR · 2026 · Co-investigator
$298,350
Short courses of oral corticosteroids and the risk of acute adverse events in mild-to-moderate asthma: a population-based real-world study
CIHR · 2025 · Nominated PI
$221,850
Optimisation of precision therapy for chronic obstructive pulmonary disease: A dynamic treatment regime analysis
CIHR · 2023 · Nominated PI
$271,576

All 36 grants and awards

From the 150 most recent of 325 publications.

Transient Oral Corticosteroid Use and Acute Upper Gastrointestinal Bleeding in Mild-to-Moderate Asthma: A Case-Crossover Study.

Li J, Ernst P, Suissa S

Drug safety2026Senior author

DOI: 10.1007/s40264-026-01699-x PMID: 42489820

Comparative Effectiveness and Safety of Fluticasone-Umeclidinium-Vilanterol and Beclomethasone-Glycopyrronium-Formoterol Single-Inhaler Triple Therapies for COPD: Real-World Observational Study [Response to Letter].

Cherian M, Suissa S

International journal of chronic obstructive pulmonary disease2026Senior author

DOI: 10.2147/copd.s633012 PMID: 42453370

Comparative Effectiveness and Safety of Fluticasone-Umeclidinium-Vilanterol and Beclomethasone-Glycopyrronium-Formoterol Single-Inhaler Triple Therapies for COPD: Real-World Observational Study.

Cherian M, Dell'Aniello S, Suissa S

International journal of chronic obstructive pulmonary disease2026Senior author

DOI: 10.2147/copd.s585037 PMID: 42136913

A systematic review of observational studies of sodium-glucose cotransporter 2 inhibitors and COVID-19 outcomes: a methodological assessment.

St-Jean A, Moriello C, Yu OHY, Suissa S, Filion KB

Journal of clinical epidemiology2026

DOI: 10.1016/j.jclinepi.2026.112347 PMID: 42203176

Glucagon-Like Peptide 1 Receptor Agonists and Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients With Type 2 Diabetes.

Noh Y, Yin H, Ben Ghezala I, Yu OHY, Suissa S, Azoulay L

Diabetes care2026

DOI: 10.2337/dc25-2577 PMID: 41701611

Influenza vaccine effectiveness in patients with chronic obstructive pulmonary disease: a cohort study emulating a randomized trial.

Galmiche S, Dell'Aniello S, Lévesque L, Suissa S

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases2026Senior author

DOI: 10.1016/j.cmi.2026.09.006 PMID: 42731630

Effectiveness of GLP-1 receptor agonists to prevent obstructive sleep apnea in patients with type 2 diabetes: active comparator, new user cohort study.

Khouri C, Dell'Aniello S, Jambon Barbara C, Azoulay L, Suissa S, Pepin JL

American journal of respiratory and critical care medicine2026

DOI: 10.1093/ajrccm/aamag474 PMID: 42745463

Antibiotics and Preterm Delivery: The Prevalent New-user Cohort Design to Resolve Immortal Time Bias.

Galmiche S, Comin E, Dell'Aniello S, Balayla J, Suissa S

Epidemiology (Cambridge, Mass.)2026Senior author

DOI: 10.1097/ede.0000000000001947 PMID: 41468587

Incretin-Based Drugs and the Risk of Dementia Among Patients with Type 2 Diabetes.

Wang YH, Johnson K, Beradid S, Yin H, Yu OHY, Suissa S, Azoulay L, Renoux C

Drug safety2026

DOI: 10.1007/s40264-025-01623-9 PMID: 41123870

Second- and Third-Generation BCR-ABL Tyrosine Kinase Inhibitors and the Risk of Pulmonary Arterial Hypertension: A Prevalent New-User Design.

Jambon-Barbara C, Suissa S, Dell'Aniello S, Hlavaty A, Cracowski JL, Chaumais MC, Humbert M, Montani D, Khouri C

Circulation2026

DOI: 10.1161/circulationaha.125.077764 PMID: 41674449

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mentionMention their CIHR grant from 2025

Subject: Prospective PhD student: Pharmacoepidemiology Dear Professor Suissa, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Transient Oral Corticosteroid Use and Acute Upper Gastrointestinal Bleeding in Mild-to-Moderate Asthma: A Case-Crossover Study." (2026), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Short courses of oral corticosteroids and the risk of acute adverse events in mild-to-moderate asthma: a population-based real-world study" (2025), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]

Something wrong or missing on this profile? Suggest a correction

Samy Suissa

Research

Latest papers

Latest funding

Transient Oral Corticosteroid Use and Acute Upper Gastrointestinal Bleeding in Mild-to-Moderate Asthma: A Case-Crossover Study.

Comparative Effectiveness and Safety of Fluticasone-Umeclidinium-Vilanterol and Beclomethasone-Glycopyrronium-Formoterol Single-Inhaler Triple Therapies for COPD: Real-World Observational Study [Response to Letter].

Comparative Effectiveness and Safety of Fluticasone-Umeclidinium-Vilanterol and Beclomethasone-Glycopyrronium-Formoterol Single-Inhaler Triple Therapies for COPD: Real-World Observational Study.

A systematic review of observational studies of sodium-glucose cotransporter 2 inhibitors and COVID-19 outcomes: a methodological assessment.

Glucagon-Like Peptide 1 Receptor Agonists and Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients With Type 2 Diabetes.

Influenza vaccine effectiveness in patients with chronic obstructive pulmonary disease: a cohort study emulating a randomized trial.

Effectiveness of GLP-1 receptor agonists to prevent obstructive sleep apnea in patients with type 2 diabetes: active comparator, new user cohort study.

Antibiotics and Preterm Delivery: The Prevalent New-user Cohort Design to Resolve Immortal Time Bias.

Incretin-Based Drugs and the Risk of Dementia Among Patients with Type 2 Diabetes.

Second- and Third-Generation BCR-ABL Tyrosine Kinase Inhibitors and the Risk of Pulmonary Arterial Hypertension: A Prevalent New-User Design.

Frequent collaborators

Laurent Azoulay

Laurent Azoulay

Christel Renoux

Paul Brassard

Marie Hudson

Antonios Douros

Janie Coulombe

Alain Bitton

Machelle Wilchesky

Oriana Yu

Maida Sewitch

Vicky Tagalakis

Sasha Bernatsky

Sasha Bernatsky

J Michael Paterson

Caroline Quach

Lawrence Joseph

Michael Pollak

Soham Rej

Deborah Assayag

Madeleine Durand

Ian Shrier

Madeleine Durand

Richeek Pradhan

Alan Barkun

Robert Platt

Caroline Hébert

Serge Gauthier

Alan Barkun

Giada Sebastiani

Serge Gauthier

Ann Clarke

Martin Rainer Kolb

Gerald Batist

Gerald Batist